SEC Form 4 · accession 0001209191-17-047947
Horizon Pharma plc · HZNP
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Miles W McHugh
Officer — Sr VP & Princ. Acctg Officer
Period of report
Aug 3, 2017
Accepted (ET)
Aug 7, 2017 · 5:52 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001492426
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Restricted Stock UnitsF1,F2 | — | Aug 3, 2017 | A | 50,000 | A | — | — | Ordinary shares | 50,000 | 50,000 | D |
Explanation of responses
- F1Each restricted stock unit represents a contingent right to receive one ordinary share of the Issuer.
- F250% of the shares subject to the restricted stock units shall vest on each of August 1, 2018 and August 1, 2019.